Abstract
Alzheimer’s disease (AD) is a degenerative neurological disease that mostly affects the elderly in numerous countries all over the world. The miRNA expression profile of GSE157239, as well as the gene expression profiles of GSE33000, GSE122063, and GSE118553, were used to identify differentially expressed miRNAs (DEMs) and differentially expressed genes (DEGs) between AD patients and healthy controls, with the objective of determining miRNAs involved in the pathogenesis of Alzheimer’s disease and recommending novel miRNA biomarkers in Alzheimer’s patients. The detected DEMs’ target genes were predicted using the mirTarBase and Tarbase databases and compared to the identified DEGs. Following that, 199 genes that overlapped between anticipated target genes from databases (mirTarBase and Tarbase) and discovered DEGs were approved as predicted target genes for DEMs. Funrich was also used to perform a Gene Ontology (GO) and pathway analysis for predicted target genes. Furthermore, the predicted target genes’ Protein–Protein Interaction (PPI) was displayed using the Cytoscape platform. PPI analysis revealed ten hub-genes of the target genes. As a consequence, 199 DEGs and 22 DEMs were revealed to be differently expressed between AD patients and healthy controls. Remarkably, type 2 diabetes was the pathway with the highest concentration of target genes. The link between diabetes and Alzheimer’s disease is thoroughly examined in the discussion section. Finally, the top detected DEMs among miRNAs were hsa-miR-125a-3p, hsa-miR-6131, hsa-miR-24-3p, hsa-miR-208a-5p, hsa-miR-6761-3p, and hsa-miR-3646. These findings significantly add to our understanding of the molecular pathways and associated miRNAs involved in the development of Alzheimer’s disease.
Similar content being viewed by others
REFERENCES
Talwar, P., Silla, Y., Grover, S., Gupta, M., Agarwal, R., Kushwaha, S., and Kukreti, R., BMC Genomics, 2014, vol. 15, no. 1, p. 199.
Kließ, M. K., Martins, R., and Connolly, M. P., J. Prev. Alzheimer’s Dis., 2021, vol. 8, no. 3, pp. 362–370.
Kotecha, A. M., Corrêa, A. D. C., Fisher, K. M., and Rushworth, J. V., Biosensors, 2018, vol. 8, no. 2., https://doi.org/10.3390/BIOS8020041
Weuve, J., Hebert, L. E., Scherr, P. A., and Evans, D. A., Alzheimers. Dement., 2014, vol. 10, no. 2, p. e40.
Barnes, J., Dickerson, B. C., Frost, C., Jiskoot, L. C., Wolk, D., and Van Der Flier, W. M., Alzheimers. Dement., 2015, vol. 11, no. 11, pp. 1349–1357.
Colom-Cadena, M., Spires-Jones, T., Zetterberg, H., Blennow, K., Caggiano, A., DeKosky, S. T., Fillit, H., Harrison, J. E., Schneider, L. S, Scheltens, P., de Haan, W., Grundman, M., van Dyck, C. H., Izzo, N. J., Catalano, S. M., and the Synaptic Health Endpoints Working Group, Alzheimers. Res. Ther., 2020, vol. 12, no. 1, https://doi.org/10.1186/S13195-020-00588-4
Westman, E., Aguilar, C., Muehlboeck, J. S., and Simmons, A., Brain Topogr., 2013, vol. 26, no. 1, pp. 9–23.
Memczak, S., Papavasileiou, P., Peters, O., and Rajewsky, N., PLoS One, 2015, vol. 10, no. 10, https://doi.org/10.1371/JOURNAL.PONE.0141214
Hammond, S. M., 2015, Adv. Drug Deliv. Rev., vol. 87, pp. 3–14.
Gebert, L. F. R. and MacRae, I. J., “Regulation of microRNA function in animals,” Nat. Rev. Mol. Cell Biol., 2018, vol. 20, no. 1, pp. 21–37.
Lu, T. X. and Rothenberg, M. E., J. Allergy Clin. Immunol., 2018, vol. 141, no. 4, pp. 1202–1207.
Bekris, L. M., Yu, C. E., Bird, T. D., and Tsuang, D. W., J. Geriatr. Psychiatry Neurol., 2010, vol. 23, no. 4, pp. 213–227.
Karch, C. M., Jeng, A. T., Nowotny, P., Cady, J., Cruchaga, C., and Goate, A. M., PLoS One, 2012, vol. 7, no. 11, https://doi.org/10.1371/JOURNAL.PONE.0050976
Dong, H., Lei, J., Ding, L., Wen, Y., Ju, H., and Zhang, X., Chem. Rev., 2013, vol. 113, no. 8, pp. 6207–6233.
Stappert, L. et al., PLoS One, 2013, vol. 8, no. 3, https://doi.org/10.1371/JOURNAL.PONE.0059011
Ferrante, M. and Conti, G. O., MicroRNA, 2017., vol. 6, no. 3, https://doi.org/10.2174/2211536606666170811151503
Kumar, P., Dezso, Z., MacKenzie, C., Oestreicher, J., Agoulnik, S., Byrne, M., Bernier, F., Yanagimachi, M., Aoshima, K., and Oda, Y., PLoS One, 2013, vol. 8, no. 7, p. e69807, https://doi.org/10.1371/JOURNAL.PONE.0069807
Femminella, G. D., Ferrara, N., and Rengo, G., Front. Physiol., 2015, vol. 6, no. FEB, p. 40, https://doi.org/10.3389/FPHYS.2015.00040/BIBTEX
Fransquet, P. D. and Ryan, J., Clin. Biochem., 2018, vol. 58, pp. 5–14.
Bekris, L. M., Lutz, F., Montine, T. J., Yu, C. E., Tsuang, D., Peskind, E. R. and Leverenz, J. B., Biomarkers, 2013, vol. 18, no. 5, pp. 455–466.
Kiko, T., Nakagawa, K., Tsuduki, T., Furukawa, K., Arai, H., and Miyazawa, T., J. Alzheimer’s Dis., 2014, vol. 39, no. 2, pp. 253–259.
Zetterberg, H. and Burnham, S. C., Mol. Brain, 2019, vol. 12, no. 1, pp. 1–7.
Cheng, L. et al., Mol. Psychiatry, 2014, vol. 20, no. 10, pp. 1188–1196.
Nagaraj, S. et al., Oncotarget, 2017, vol. 8, no. 10, pp. 16122–16143.
Kalra, H., Drummen, G. P. C., and Mathivanan, S., Int. J. Mol. Sci., 2016, vol. 17, no. 2, https://doi.org/10.3390/IJMS17020170
Barbagallo, C. et al., Cell. Mol. Neurobiol., 2020, vol. 40, no. 4, pp. 531–546.
Ren, L., Zhou, X., Huang, X., Wang, C., and Li, Y., Life Sci., 2019, vol. 217, pp. 229–236.
de la Monte, S. M., BMB Rep., 2009, vol. 42, no. 8, p. 475.
De Ferrari, G. V. and Inestrosa, N. C., Brain Res. Rev., 2000, vol. 33, no. 1, pp. 1–12.
Desale, S. E., and Chinnathambi, S., Cell Commun. Signal., 2021, vol. 19, no. 1, pp. 1–12.
Uddin, M. S. et al., IUBMB Life, 2020, vol. 72, no. 9, pp. 1843–1855.
Sun, P. et al., Biosci. Rep., 2019, vol. 39, no. 1, p. 20180902.
Singulani, M. P. et al., Exp. Gerontol., 2020, vol. 133, https://doi.org/10.1016/J.EXGER.2020.110882
Rizzi, L. and Roriz-Cruz, M., Neuropeptides, 2018, vol. 71, pp. 54–60.
Cheng, Y., and Bai, F., Front. Neurosci., 2018, vol. 12, no. MAR, p. 163, https://doi.org/10.3389/FNINS.2018.00163/BIBTEX
Choi, E. J., Son, Y. D., Noh, Y., Lee, H., Kim, Y. B., and Park, K. H., J. Clin. Neurol., 2018, vol. 14, no. 2, pp. 158–164.
Kellar, D. and Craft, S., Lancet Neurol., 2020, vol. 19, no. 9, pp. 758–766.
Chang, W. et al., J. Agric. Food Chem., 2019. vol. 67, no. 27, pp. 7684–7693.
Femminella, G. D. et al., J. Diabetes Res., 2017, vol. 2017, https://doi.org/10.1155/2017/7420796
Checler, F., Goiran, T., and Alves da Costa, C., Autophagy, 2018, vol. 14, no. 6, pp. 1099–1101.
Kowalska, M., Wize, K., Prendecki, M., Lianeri, M., Kozubski, W., and Dorszewska, J., Curr. Alzheimer Res., 2020, vol. 17, no. 3, pp. 208–223.
Cheignon, C., Tomas, M., Bonnefont-Rousselot, D., Faller, P., Hureau, C., and Collin, F., Redox Biol., 2018, vol. 14, pp. 450–464.
Kim, J. K., Kim, T. S., Basu, J., and Jo, E. K., Cell. Microbiol., 2017, vol. 19, no. 1, p. e12687.
Lopez-Ramirez, M. A., Reijerkerk, A., De Vries, H. E., and Romero, I. A., FASEB J., 2016,vol. 30, no. 8, pp. 2662–2672.
Yllmaz, Ş. G., Erdal, M. E., Özge, A. A., and Sungur, M. A., OMICS, 2016, vol. 20, no. 8, pp. 456–461.
Aguilar, B. J., Zhu, Y., and Lu, Q., Alzheimer’s Res. Ther., 2017, vol. 9, no. 1, pp. 1–10.
Mano, T. et al., Proc. Natl. Acad. Sci. U. S. A., 2017, vol. 114, no. 45, pp. E9645–E9654.
Ahmad, S. et al., Sci. Reports, 2020, vol. 10, no. 1, pp. 1–13.
Khan, R., Kadamkode, V., Kesharwani, D., Purkayastha, S., Banerjee, G., and Datta, M., RNA Biol., 2020, vol. 17, no. 2, pp. 188–201.
Lugli, G.et al., PLoS One, 2015, vol. 10, no. 10, p. e0139233.
Villa, C. et al., Rejuvenation Res., 2011, vol. 14, no. 3, pp. 275–281.
Sellers, K. J.et al., Alzheimer’s Dement., 2018, vol. 14, no. 3, p. 306, https://doi.org/10.1016/J.JALZ.2017.09.008
Lin, F., Zhang, H., Bao, J., and Li, L., World Neurosurg., 2021, vol. 153, pp. e315–e328.
Liu, L., Liu, L., Lu, Y., Zhang, T., and Zhao, W., Biomark. Med., vol. 15, no. 16, pp. 1499–1507.
Ji, Q., Wang, X., Cai, J., Du, X., Sun, H., and Zhang, N., 2019, Curr. Neurovasc. Res., vol. 16, no. 5, pp. 473–480.
Lee, H. G. et al., Am. J. Pathol., 2009, vol. 174, no. 3, p. 891, https://doi.org/10.2353/AJPATH.2009.080583
Woodbury, M. E. and Ikezu, T., J. Neuroimmune Pharmacol., 2014, vol. 9, no. 2, pp. 92–101.
Funding
No external funding was received.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest. The authors declare that they have no conflict of interest.
Consent for publication. The authors have stated that their interests do not conflict with each other.
Institutional Review Board Statement. This article does not contain any studies with human participants or animals performed by any of the authors.
Consent to participate. No individual information was used in this study
Availability of data and material. All the analysed information has been published in this article
Authors’ contributions. Alireza Rahimpour, Roozbeh Heidarzadehpilehrood, Majid Aghel, Zahra Jamalpoor, Parichehr Heydarian, Seyed Abbas Ghasemi, and Maryam Pirhoushiaran served as co-first authors on this study and contributed equally to the writing, reviewing, and editing. Maryam Pirhoushiaran served as project supervisor. All authors approved the final manuscript’s contents for publication.
Additional information
Corresponding author; address: Department of Medical Genetics, Ground Floor, Building No. 8, School of Medicine, East Door, Tehran University of Medical Sciences, Ghods St., Enghelab St., Tehran, Iran; phone: +989190227143; е-mail: maryam.pirhoushiaran@gmail.com.
Rights and permissions
About this article
Cite this article
Rahimpour, A., Heidarzadehpilehrood, R., Aghel, M. et al. Bioinformatics Analysis of MicroRNA Profiles Unveils Novel Biological Markers of Alzheimer’s Disease. Neurochem. J. 16, 334–342 (2022). https://doi.org/10.1134/S1819712422030096
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1819712422030096